JoVE Logo
Faculty Resource Center

Sign In

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

DOI :

10.3791/54170-v

September 1st, 2016

September 1st, 2016

8,601 Views

1Neurotrauma Research, Swedish Medical Center, 2Neurosurgery, Colorado Brain and Spine Institute

Our studies have revealed that the beneficial effects of conivaptan are dependent on the method of delivery after experimental stroke in mice. We have developed a research protocol for delivery of the receptor blocker via IV catheter on stroke-evoked brain edema formation in mice.

-- Views

Related Videos

article

A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

article

Author Spotlight: Advancing Male Infertility Research by Unraveling Sperm Metabolism and Mitochondrial Function

article

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting

article

Author Spotlight: Context Dependent Blood Collection Methods in Rats

article

Author Spotlight: Understanding the Mechanism of Tuina Manipulation in Rats

article

Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation

article

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

article

Analgesic Effect of Tuina on Rat Models with Compression of the Dorsal Root Ganglion Pain

article

A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition

article

Author Spotlight: Comparing Alveolar and Long Bone Remodeling to Explore OTM Model Potential

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved